Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2003-04-15

AUTHORS

S Ciatto, S Cecchini, G Gervasi, A Landini, M Zappa, E Crocetti

ABSTRACT

The association of endometrial thickness with the risk of developing endometrial cancer (EC) within 2 years was investigated in a consecutive cohort of 1205 breast cancer patients under tamoxifen treatment, undergoing transvaginal ultrasonography (TVUS) for follow-up purpose (asymptomatic, 1068) or for abnormal uterine bleeding (AUB, 137). Linkage with tumour registry allowed for the follow-up of 3184.3 person-years. According to underlying incidence, 1.85 EC cases were expected in the study cohort while 12 were observed (observed/expected ratio=6.49, 95% CI 3.35-11.33; asymptomatic=4.09, 95% CI 1.65-8.43, symptomatic=35.71, 95% CI 11.59-83.34). No EC was observed with thickness (half layer) <3 mm. Raising this threshold increased specificity with a substantial loss of sensitivity (>or=3, >or=4, >or=6, >or=9 mm; spec.=25.8, 44.5, 76.1, 91.5%, sens.=100, 91.6, 75.0, 66.6%). The presence of AUB was rather specific (88.94%) but poorly sensitive (41.67%). A combination of AUB presence/absence and thickness allowed the best accuracy (AUB + thickness >or=3, >or=4 or >or=5; sens.=100, 81.6 or 91.6%; spec.=22.8, 40.4, or 56.7%). Breast cancer patients under tamoxifen might be selected for further invasive assessment on the basis of AUB and endometrial thickness assessed at TVUS. More... »

PAGES

1175-1179

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6600894

DOI

http://dx.doi.org/10.1038/sj.bjc.6600894

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047589526

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12698180


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Hormonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endometrial Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Invasiveness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Second Primary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tamoxifen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ultrasonography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vagina", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ciatto", 
        "givenName": "S", 
        "id": "sg:person.01174274056.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174274056.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cecchini", 
        "givenName": "S", 
        "id": "sg:person.01056612350.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056612350.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gervasi", 
        "givenName": "G", 
        "id": "sg:person.01044571120.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044571120.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Landini", 
        "givenName": "A", 
        "id": "sg:person.0700441664.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700441664.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zappa", 
        "givenName": "M", 
        "id": "sg:person.013651510165.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013651510165.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/grid.417623.5", 
          "name": [
            "Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crocetti", 
        "givenName": "E", 
        "id": "sg:person.0700466552.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700466552.06"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2003-04-15", 
    "datePublishedReg": "2003-04-15", 
    "description": "The association of endometrial thickness with the risk of developing endometrial cancer (EC) within 2 years was investigated in a consecutive cohort of 1205 breast cancer patients under tamoxifen treatment, undergoing transvaginal ultrasonography (TVUS) for follow-up purpose (asymptomatic, 1068) or for abnormal uterine bleeding (AUB, 137). Linkage with tumour registry allowed for the follow-up of 3184.3 person-years. According to underlying incidence, 1.85 EC cases were expected in the study cohort while 12 were observed (observed/expected ratio=6.49, 95% CI 3.35-11.33; asymptomatic=4.09, 95% CI 1.65-8.43, symptomatic=35.71, 95% CI 11.59-83.34). No EC was observed with thickness (half layer) <3 mm. Raising this threshold increased specificity with a substantial loss of sensitivity (>or=3, >or=4, >or=6, >or=9 mm; spec.=25.8, 44.5, 76.1, 91.5%, sens.=100, 91.6, 75.0, 66.6%). The presence of AUB was rather specific (88.94%) but poorly sensitive (41.67%). A combination of AUB presence/absence and thickness allowed the best accuracy (AUB + thickness >or=3, >or=4 or >or=5; sens.=100, 81.6 or 91.6%; spec.=22.8, 40.4, or 56.7%). Breast cancer patients under tamoxifen might be selected for further invasive assessment on the basis of AUB and endometrial thickness assessed at TVUS.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6600894", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "88"
      }
    ], 
    "keywords": [
      "breast cancer patients", 
      "endometrial cancer", 
      "transvaginal ultrasonography", 
      "cancer patients", 
      "endometrial thickness", 
      "abnormal uterine bleeding", 
      "uterine bleeding", 
      "Tumor Registry", 
      "study cohort", 
      "invasive assessment", 
      "consecutive cohort", 
      "EC cases", 
      "patients", 
      "ultrasonography", 
      "cohort", 
      "cancer", 
      "treatment", 
      "presence/absence", 
      "AUB", 
      "bleeding", 
      "tamoxifen", 
      "registry", 
      "incidence", 
      "risk", 
      "surveillance", 
      "association", 
      "substantial loss", 
      "years", 
      "specificity", 
      "assessment", 
      "absence", 
      "cases", 
      "sensitivity", 
      "loss", 
      "presence", 
      "threshold", 
      "purpose", 
      "combination", 
      "thickness", 
      "basis", 
      "accuracy", 
      "good accuracy", 
      "presence of AUB", 
      "AUB presence/absence", 
      "further invasive assessment", 
      "basis of AUB"
    ], 
    "name": "Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment", 
    "pagination": "1175-1179", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047589526"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6600894"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12698180"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6600894", 
      "https://app.dimensions.ai/details/publication/pub.1047589526"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_378.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6600894"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600894'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600894'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600894'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600894'


 

This table displays all metadata directly associated to this object as RDF triples.

191 TRIPLES      21 PREDICATES      84 URIs      76 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6600894 schema:about N2b7e80466c34483681fae1412639f7ba
2 N3ade44272e784c1bb90981d1415d0a51
3 N4678498d3d9b467b9a4830f1edb15cde
4 N4a5933abe528408b9a7f61a09b4b2923
5 N586f4caf90d54c94b5248378e6e918e0
6 N7663194d6c134b8883f255fca51c972c
7 N76be34eabb614247a201121c6a5d7cb4
8 N78069daaa26d477eba8fdb816486fa2e
9 N78ce7570420d471aaafca9e7aa3ca4fb
10 N78ef59e628524d768ec556a1b209337a
11 N88c270b444e341d5a1a44f726a40e787
12 Nd2893e0b00cd42fbb73bcbcb9ca532d7
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author Nafdd3974054e466ab55bf9f09f26f511
16 schema:datePublished 2003-04-15
17 schema:datePublishedReg 2003-04-15
18 schema:description The association of endometrial thickness with the risk of developing endometrial cancer (EC) within 2 years was investigated in a consecutive cohort of 1205 breast cancer patients under tamoxifen treatment, undergoing transvaginal ultrasonography (TVUS) for follow-up purpose (asymptomatic, 1068) or for abnormal uterine bleeding (AUB, 137). Linkage with tumour registry allowed for the follow-up of 3184.3 person-years. According to underlying incidence, 1.85 EC cases were expected in the study cohort while 12 were observed (observed/expected ratio=6.49, 95% CI 3.35-11.33; asymptomatic=4.09, 95% CI 1.65-8.43, symptomatic=35.71, 95% CI 11.59-83.34). No EC was observed with thickness (half layer) <3 mm. Raising this threshold increased specificity with a substantial loss of sensitivity (>or=3, >or=4, >or=6, >or=9 mm; spec.=25.8, 44.5, 76.1, 91.5%, sens.=100, 91.6, 75.0, 66.6%). The presence of AUB was rather specific (88.94%) but poorly sensitive (41.67%). A combination of AUB presence/absence and thickness allowed the best accuracy (AUB + thickness >or=3, >or=4 or >or=5; sens.=100, 81.6 or 91.6%; spec.=22.8, 40.4, or 56.7%). Breast cancer patients under tamoxifen might be selected for further invasive assessment on the basis of AUB and endometrial thickness assessed at TVUS.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree true
22 schema:isPartOf N0c347575510945fc82b1feac3d858ecf
23 Nd04b46981648412f8725c135b99ab249
24 sg:journal.1017082
25 schema:keywords AUB
26 AUB presence/absence
27 EC cases
28 Tumor Registry
29 abnormal uterine bleeding
30 absence
31 accuracy
32 assessment
33 association
34 basis
35 basis of AUB
36 bleeding
37 breast cancer patients
38 cancer
39 cancer patients
40 cases
41 cohort
42 combination
43 consecutive cohort
44 endometrial cancer
45 endometrial thickness
46 further invasive assessment
47 good accuracy
48 incidence
49 invasive assessment
50 loss
51 patients
52 presence
53 presence of AUB
54 presence/absence
55 purpose
56 registry
57 risk
58 sensitivity
59 specificity
60 study cohort
61 substantial loss
62 surveillance
63 tamoxifen
64 thickness
65 threshold
66 transvaginal ultrasonography
67 treatment
68 ultrasonography
69 uterine bleeding
70 years
71 schema:name Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment
72 schema:pagination 1175-1179
73 schema:productId N5a494e4f482c4a42a9ae1d818bb6fd32
74 N86984fe28c7d4f358915228afb57b79d
75 Nbbe6a37a2a5e44c58a3ff6b04a57f981
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047589526
77 https://doi.org/10.1038/sj.bjc.6600894
78 schema:sdDatePublished 2022-01-01T18:13
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher N365bddeb3bc14a69bdfe6e02d1b2c3dc
81 schema:url https://doi.org/10.1038/sj.bjc.6600894
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N0c347575510945fc82b1feac3d858ecf schema:issueNumber 8
86 rdf:type schema:PublicationIssue
87 N2b7e80466c34483681fae1412639f7ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Tamoxifen
89 rdf:type schema:DefinedTerm
90 N365bddeb3bc14a69bdfe6e02d1b2c3dc schema:name Springer Nature - SN SciGraph project
91 rdf:type schema:Organization
92 N3ade44272e784c1bb90981d1415d0a51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Vagina
94 rdf:type schema:DefinedTerm
95 N4678498d3d9b467b9a4830f1edb15cde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Middle Aged
97 rdf:type schema:DefinedTerm
98 N49e368920873435aa19a38f667cc7d21 rdf:first sg:person.01044571120.38
99 rdf:rest Na2f3e7230884451baaa2cee7b91b933a
100 N4a5933abe528408b9a7f61a09b4b2923 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Antineoplastic Agents, Hormonal
102 rdf:type schema:DefinedTerm
103 N57c001d6e2a54c53ada864a36be9c107 rdf:first sg:person.01056612350.53
104 rdf:rest N49e368920873435aa19a38f667cc7d21
105 N586f4caf90d54c94b5248378e6e918e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Breast Neoplasms
107 rdf:type schema:DefinedTerm
108 N5a494e4f482c4a42a9ae1d818bb6fd32 schema:name doi
109 schema:value 10.1038/sj.bjc.6600894
110 rdf:type schema:PropertyValue
111 N6acc81d5cc5b4970abc7f2e62fc14603 rdf:first sg:person.013651510165.31
112 rdf:rest Nc11e583f7ee54c89b023fbe8323132fb
113 N7663194d6c134b8883f255fca51c972c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Female
115 rdf:type schema:DefinedTerm
116 N76be34eabb614247a201121c6a5d7cb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Ultrasonography
118 rdf:type schema:DefinedTerm
119 N78069daaa26d477eba8fdb816486fa2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Humans
121 rdf:type schema:DefinedTerm
122 N78ce7570420d471aaafca9e7aa3ca4fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Neoplasm Invasiveness
124 rdf:type schema:DefinedTerm
125 N78ef59e628524d768ec556a1b209337a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Endometrial Neoplasms
127 rdf:type schema:DefinedTerm
128 N86984fe28c7d4f358915228afb57b79d schema:name dimensions_id
129 schema:value pub.1047589526
130 rdf:type schema:PropertyValue
131 N88c270b444e341d5a1a44f726a40e787 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Neoplasms, Second Primary
133 rdf:type schema:DefinedTerm
134 Na2f3e7230884451baaa2cee7b91b933a rdf:first sg:person.0700441664.51
135 rdf:rest N6acc81d5cc5b4970abc7f2e62fc14603
136 Nafdd3974054e466ab55bf9f09f26f511 rdf:first sg:person.01174274056.26
137 rdf:rest N57c001d6e2a54c53ada864a36be9c107
138 Nbbe6a37a2a5e44c58a3ff6b04a57f981 schema:name pubmed_id
139 schema:value 12698180
140 rdf:type schema:PropertyValue
141 Nc11e583f7ee54c89b023fbe8323132fb rdf:first sg:person.0700466552.06
142 rdf:rest rdf:nil
143 Nd04b46981648412f8725c135b99ab249 schema:volumeNumber 88
144 rdf:type schema:PublicationVolume
145 Nd2893e0b00cd42fbb73bcbcb9ca532d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Aged
147 rdf:type schema:DefinedTerm
148 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
149 schema:name Medical and Health Sciences
150 rdf:type schema:DefinedTerm
151 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
152 schema:name Oncology and Carcinogenesis
153 rdf:type schema:DefinedTerm
154 sg:journal.1017082 schema:issn 0007-0920
155 1532-1827
156 schema:name British Journal of Cancer
157 schema:publisher Springer Nature
158 rdf:type schema:Periodical
159 sg:person.01044571120.38 schema:affiliation grid-institutes:grid.417623.5
160 schema:familyName Gervasi
161 schema:givenName G
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044571120.38
163 rdf:type schema:Person
164 sg:person.01056612350.53 schema:affiliation grid-institutes:grid.417623.5
165 schema:familyName Cecchini
166 schema:givenName S
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056612350.53
168 rdf:type schema:Person
169 sg:person.01174274056.26 schema:affiliation grid-institutes:grid.417623.5
170 schema:familyName Ciatto
171 schema:givenName S
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174274056.26
173 rdf:type schema:Person
174 sg:person.013651510165.31 schema:affiliation grid-institutes:grid.417623.5
175 schema:familyName Zappa
176 schema:givenName M
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013651510165.31
178 rdf:type schema:Person
179 sg:person.0700441664.51 schema:affiliation grid-institutes:grid.417623.5
180 schema:familyName Landini
181 schema:givenName A
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700441664.51
183 rdf:type schema:Person
184 sg:person.0700466552.06 schema:affiliation grid-institutes:grid.417623.5
185 schema:familyName Crocetti
186 schema:givenName E
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700466552.06
188 rdf:type schema:Person
189 grid-institutes:grid.417623.5 schema:alternateName Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy
190 schema:name Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Firenze, Italy
191 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...